Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2015

View Archived Issues

Sprint Bioscience and Bayer sign collaboration and license agreement for tumor metabolism program

Apogenix and R-Biopharm partner on companion diagnostics for APG-101

Foundation Medicine initiates study of circulating tumor DNA assay

Oragenics and Intrexon report positive activity for lantibiotics in C. difficile model

PhytoTech Medical completes acquisition of MMJ Bioscience

Viking Therapeutics to conduct phase II study of VK-2809

CDX-085 shows superior bioavailability to microalgal astaxanthin in monkey study

AEterna Zentaris reveals optimized ERK inhibitor and back-up compounds

Sumitomo Dainippon Pharma offers overview of first quarter of fiscal 2015

ARIAD to use ponatinib financing to develop brigatinib

Recombinant protein shows antitumor effect and improves paclitaxel efficacy

Tesaro and Jiangsu Hengrui medicine form rolapitant license agreement for China

Ascendis Pharma reports topline results from a phase II pediatric study of TransCon Growth Hormone

Roche patents neurogenesis-stimulating compounds

Bayer divulges MNK1 inhibitors

Aurigene introduces IRAK-4 inhibitors

Rgenix presents LXR agonists

Piramal patents EZH2 inhibitors

Novel myristoylated peptide aptamer acts as N-type calcium channel blocker for analgesic effects

Roche files PMA for EGFR mutation test as companion diagnostic to AZD-9291

Scripps Florida researchers receive two NIH grants

Scancell and ImmunID to use ImmunTraCkeR to predict response to SCIB-1

GI Dynamics ends pivotal U.S. trial of EndoBarrier

Mayo Clinic and Diadexus collaborate on PLAC Lp-PLA2 test

Eisai files for approval of eribulin in soft tissue sarcoma in U.S., E.U. and Japan

Kyowa Hakko Kirin files for Japanese approval of brodalumab

Takeda Pharmaceutical updates key activities of first quarter of fiscal 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...